Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3
Oxidative Medicine and Cellular Longevity · 2023
DOI: 10.1155/2023/9966355 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oxidative Medicine and Cellular Longevity, 2023. Verfasst von Wei Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China. Hauptthemen laut MEDLINE: Sirtuin 3, Heart Injuries. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Technical Innovation Project of Hubei Province of China.
Abstract (Originalsprache)
Cardiotoxicity linked to doxorubicin (DOX) is primarily caused by inflammation, oxidative stress, and apoptosis. The role of tubeimoside I (TBM) in DOX-induced cardiotoxicity remains ambiguous, despite growing evidence that it could reduce inflammation, oxidative stress, and apoptosis in various diseases. This study was designed to investigate the role of TBM in DOX-induced cardiotoxicity and uncover the underlying mechanisms. H9c2 cell line and C57BL/6 mice were used to construct an in vitro and in vivo model of DOX-induced myocardial injury, respectively. We observed that DOX treatment provoked inflammation, oxidative stress, and cardiomyocyte apoptosis, which were significantly alleviated by TBM administration. Mechanistically, TBM attenuated DOX-induced downregulation of sirtuin 3 (SIRT3), and SIRT3 inhibition abrogated the beneficial effects of TBM both in vitro and in vivo. In conclusion, TBM eased inflammation, oxidative stress, and apoptosis in DOX-induced cardiotoxicity by increasing the expression of SIRT3, suggesting that it holds great promise for treating DOX-induced cardiac injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Cardiovascular Research Institute, Wuhan University, Wuhan 430060, China.
- Hubei Key Laboratory of Cardiology, Wuhan 430060, China.
- Department of Cardiology, The First College of Clinical Medical Sciences, China Three Gorges University & Yichang Central People's Hospital, Yichang, 443000 Hubei Province, China.
ORCID-Profile: Wei Zhang, Jinchun Wu, Congxin Huang
Förderung
- National Natural Science Foundation of China
- Technical Innovation Project of Hubei Province of China
Zitieren
APA
Zhang, W., Fan, Z., Wang, F., Yin, L., Wu, J., Li, D., Song, S., Wang, X., Tang, Y., & Huang, C. (2023). Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/2023/9966355
Vancouver
Zhang W, Fan Z, Wang F, Yin L, Wu J, Li D, et al. Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3. Oxidative Medicine and Cellular Longevity. 2023. doi:10.1155/2023/9966355
BibTeX
@article{Zhang2023,
author = {Zhang, Wei and Fan, Zhixing and Wang, Fengyuan and Yin, Lin and Wu, Jinchun and Li, Dengke and Song, Siwei and Wang, Xi and Tang, Yanhong and Huang, Congxin},
title = {Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3},
journal = {Oxidative Medicine and Cellular Longevity},
year = {2023},
doi = {10.1155/2023/9966355}
}
EUVIMED